Jun 18, 2025 17:00
BBNX - Beta Bionics, Inc. Common Stock
| Day | 1m | 10m | 60m | PreMarket | Market | AfterHours | Gap |
|---|---|---|---|---|---|---|---|
| 28.97 2.39 (8.25%) | -0.01 (-0.03%) | -0.07 (-0.21%) | -0.3 (-0.96%) | 0.0 (0.0%) | 3.13 (11.09%) | 0.0 (0.0%) | 0.77 (2.73%) |
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company product includes the iLet Bionic Pancreas (iLet). The Company operates as a single segment, focused on the development, manufacture and sale of the iLet.
Market Period:
Market
Earnings & Ratios
- Basic EPS:
- -0.39
- Diluted EPS:
- -0.39
- Basic P/E:
- -80.4103
- Diluted P/E:
- -80.4103
- RSI(14) 1m:
- 28.42
- VWAP:
- 31.37
- RVol:
Events
| Period | Kind | Movement | Occurred At |
|---|
Related News
Jun 02, 2025 12:11
Jan 31, 2025 22:56